Evidence map›Paper›PMID 33853804›Full record

ArticleBMJ open2021

Barthel Index-based functional status as a prognostic factor in young and middle-aged adults with newly diagnosed gastric, colorectal and lung cancer: a multicentre retrospective cohort study.

Toshitaka Morishima, Akira Sato, Kayo Nakata, Yoshifumi Matsumoto, Nobuyuki Koeda, Hiroko Shimada, Tsutomu Maruhama, Daisaku Matsuki, Isao Miyashiro

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Temporal trends in time toxicity of R-CHOP: a nationwide hospital-based database analysis in Japan.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Toshitaka MorishimaCancer Control Center, Osaka International Cancer Institute, Osaka, Japan morishima.t@oici.jp.ORCID 0000-0002-0747-3287
Akira SatoCancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Kayo NakataCancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Yoshifumi MatsumotoOsaka Medical and Pharmaceutical University Hospital, Takatsuki, Japan.
Nobuyuki KoedaYao Municipal Hospital, Yao, Japan.
Hiroko ShimadaNational Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan.
Tsutomu MaruhamaDepartment of Health Information Management, Higashisumiyoshi Morimoto Hospital, Osaka, Japan.
Daisaku MatsukiSaiseikai Suita Hospital, Suita, Japan.
Isao MiyashiroCancer Control Center, Osaka International Cancer Institute, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesFunctional status assessments of activities of daily living may improve prognostic precision during initial diagnostic evaluations in young and middle-aged adults with cancer. However, the association between pretreatment functional status and survival in these patients is poorly understood. This study aimed to evaluate the prognostic value of functional status in young and middle-aged patients with cancer.

designMulticentre retrospective cohort study.

settingWe used a cancer registry from Osaka Prefecture, Japan. The data were linked to administrative claims data from 35 hospitals in the same prefecture.

participantsPatients aged 18-69 years who received new diagnoses of gastric, colorectal or lung cancer between 2010 and 2014.

main outcome measureCox proportional hazards models of 5-year all-cause mortality were developed to examine the prognostic impact of pretreatment functional status, which was categorised into three levels of functional disability (none, moderate and severe) based on Barthel Index scores. The models controlled for age, sex, comorbidities, cancer stage and tumour histology.

resultsWe analysed 12 134 patients. Higher mortality risks were significantly associated with moderate functional disability (adjusted HR 1.44 (95% CI 1.18 to 1.75), 1.35 (95% CI 1.08 to 1.68) and 1.74 (95% CI 1.50 to 2.03) in patients with gastric, colorectal and lung cancer, respectively) and severe functional disability (adjusted HR 3.56 (95% CI 2.81 to 4.51), 2.37 (95% CI 1.89 to 2.95) and 2.34 (95% CI 2.00 to 2.75) in patients with gastric, colorectal and lung cancer, respectively).

conclusionAccounting for functional status at cancer diagnosis may improve the prediction of survival time in young and middle-aged adults with cancer. Functional status has potential applications in survival predictions and risk adjustments when analysing outcomes in patients with cancer.

Indexed as

Colorectal NeoplasmsLung NeoplasmsActivities of Daily LivingAdolescentAdultAgedFunctional StatusHumansJapanMiddle AgedPrognosisProportional Hazards ModelsRetrospective StudiesYoung Adultadult oncologyepidemiologyquality in health care

Identifiers

PMID33853804
PMCPMC8054075

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.